Abstract
It is a pleasure to discuss a chapter that so admirably sets forth the major issues in behavioral assessment of pharmacotherapy with the developmentally disabled. Schroeder (Chapter 9) presents, in highly compact form, a number of insights that have been painstakingly achieved during the relatively brief history of pharmacotherapy of the developmentally disabled child. The chapter highlights the importance of bridging the gaps between the “two cultures” of behavior and neuropharmacology, at both the methodologie and conceptual levels. The interplay between the behaviorally oriented clinician, the basic neuropharmacologist and neurobiologist, the animal pharmacologist, and the child psychiatrist is evident in this chapter and undoubtedly reflects a point of view nurtured by the interaction of these disciplines in a clinical-academic setting. The paper provides a useful outline of both methodological and conceptual issues, some of which I will consider further.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Conners, C. K., & Wells, K. C. (1982). Single-case design in psychopharmacology. In A. E. Kazdin & A. H. Tuma (Eds.), Single-case research designs, (pp. 61–77 ) Washington: Jossey-Bass.
Costello, A. J., Edelbrock, C. S., Dulcan, M. K., Kalas, Kessler, & Klarica. (1984). Report on the NIMH Diagnostic Interview Schedule for Children (DISC). Unpublished.
Kazdin, A. E.,Tuma, A. H. (Eds.). (1982). Single-case research designs. Washington: Jossey- Bass.
Orvaschel, H. (1985). Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacology Bulletin, 21, 737–745.
Pelham, W. (1983). The effects of psychostimulants on academic achievement in hyperactive and learning-disabled children. Thalamus, 3, 1–48.
Rapoport, J.L. (1985). DSM-III-R and pediatric psychopharmacology. Psychopharmacology Bulletin, 21, 803–806.
Solanto, M. V., & Conners, C. K. (1982). A dose-response and time-action analysis of autonomic and behavioral effects of methylphenidate in Attention Deficit Disorder with Hyperactivity. Psychophysiology, 19, 658–667.
Sprague, R., & Sleator, E. (1977). Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science, 198, 1274–1276.
Wells, K. C., Conners, C. K., Imber, L., & Delamater, A. (1981). Use of single-subject methodology in clinical decision-making with a hyperactive child on the psychiatric inpatient unit. Behavioral Assessment, 3, 359–369.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Conners, C.K. (1988). Pharmacotherapy in Developmental Disabilities. In: Russo, D.C., Kedesdy, J.H. (eds) Behavioral Medicine with the Developmentally Disabled. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0999-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0999-4_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8285-3
Online ISBN: 978-1-4613-0999-4
eBook Packages: Springer Book Archive